The post-thrombotic syndrome (PTS) is a form of chronic venous insufficiency secondary to
prior deep vein thrombosis (DVT). It affects up to 50% of patients after proximal DVT. There …

The postthrombotic syndrome (PTS) is chronic venous insufficiency secondary to a prior
deep vein thrombosis (DVT). It is the most common complication of venous …

Introduction Post-thrombotic syndrome (PTS) is a burdensome long-term complication of
deep vein thrombosis (DVT). Recent studies have suggested that rivaroxaban may reduce …

Background Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to
warfarin reduces the risk of post‐thrombotic syndrome (PTS) after deep vein thrombosis …

Abstract Objective Direct oral anticoagulants (DOACs) have been recommended for the
treatment of deep vein thrombosis (DVT). However, the benefits are uncertain for the …

Objective: Endothelial progenitor cells-released extracellular vesicles (EPCs-EVs) have
previously been reported to promote the dissolution of deep venous thrombosis (DVT) …

Acute deep vein thrombosis (DVT) causes substantial short-term and long-term patient
morbidity. Medical, lifestyle, and compressive therapies have been investigated for the …

The incidence of post-thrombotic syndrome (PTS) in patients with deep vein thrombosis
(DVT) treated with direct oral anticoagulants (DOACs) remains a matter of debate. Hence …

Background Postthrombotic syndrome (PTS) is a long‐term complication after deep vein
thrombosis (DVT) and can affect quality of life (QoL). Pathogenesis is not fully understood …

Deep venous thrombosis (DVT) constitutes a great threat to health worldwide. Endothelial
cell injury and dysfunction comprise the critical contributor for the development of DVT …